Apixaban Has Lower Bleeding Risk for Initial Anticoagulation for Venous Thromboembolism
During extended treatment, bleeding risk was similar for apixaban and rivaroxaban
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.